World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
54798
World Ranking
5691
National Ranking
3066

David J. Sugarbaker publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David J. Sugarbaker sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 447 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David J. Sugarbaker D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David J. Sugarbaker sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David J. Sugarbaker was affiliated with Baylor College of Medicine in the United States and contributed extensively to the field of medicine, with a primary focus on pulmonary and respiratory medicine. Their research encompassed various subfields including surgery, oncology, and radiology, nuclear medicine, and imaging.

The scientist's work covered multiple topics, notably occupational and environmental lung diseases, as well as pleural and pulmonary diseases. Other key areas of research included medical imaging and pathology studies, lung cancer diagnosis and treatment, lung cancer treatments and mutations, lung cancer research studies, and radiation dose and imaging.

Frequent co-authors who collaborated with David J. Sugarbaker included Marc De Leval, Steven Swanson, Michael T. Jaklitsch, Raphael Bueno, and Bryan M. Burt.

David J. Sugarbaker published research in several venues, with the highest number of publications appearing in the Journal of Thoracic and Cardiovascular Surgery. Other journals featuring their work included Annals of Surgery, Journal of Thoracic Disease, The Annals of Thoracic Surgery, and Journal of Thoracic Oncology.

Recent papers authored or co-authored by the scientist included the following:

  • Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma, 2020, Annals of Surgery
  • Completion pneumonectomy is safe and effective in select patients with recurrent non-small cell lung cancer, 2020, Journal of Thoracic Disease
  • Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging, 2020, The Annals of Thoracic Surgery
  • Reply to Waller et al. Standardizing Surgical Treatment for Mesothelioma, 2020, Journal of Thoracic Oncology
  • Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781, 2020, UNC Libraries

In addition to research papers, David J. Sugarbaker contributed to book publications, including the title "Tratado de Cirurgia Torácica," published in 2024 by Even3 Publicações eBooks.

Best Publications

  • Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery

    T. H. Lee;E. R. Marcantonio;C. M. Mangione;E. J. Thomas

  • Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

    Arindam Bhattacharjee;William G. Richards;Jane Staunton;Cheng Li

  • Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

    Joel Tepper;Mark J. Krasna;Donna Niedzwiecki;Donna Hollis

  • Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

    David J. Sugarbaker;Raja M. Flores;Michael T. Jaklitsch;William G. Richards

  • Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

    Gary M. Strauss;James E. Herndon;Michael A. Maddaus;David W. Johnstone

  • Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context

    Brock C. Christensen;E. Andres Houseman;E. Andres Houseman;Carmen J. Marsit;Shichun Zheng

  • EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

    Jussi P. Koivunen;Craig Mermel;Kreshnik Zejnullahu;Carly Murphy

  • A Clinical Prediction Rule for Delirium After Elective Noncardiac Surgery

    E R Marcantonio;L Goldman;C M Mangione;L E Ludwig

  • Non–Small Cell Lung Cancer

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Andrew Chang

  • Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

    Kevin S. Hughes;Lauren A. Schnaper;Donald Berry;Constance Cirrincione

  • Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.

    Gavin J. Gordon;Roderick V. Jensen;Li Li Hsiao;Steven R. Gullans

  • Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.

    L. Kobzik;D. S. Bredt;C. J. Lowenstein;J. Drazen

  • Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

    Raphael Bueno;Eric W Stawiski;Leonard D Goldstein;Steffen Durinck

  • Video-Assisted Thoracic Surgery Lobectomy: Report of CALGB 39802—A Prospective, Multi-Institution Feasibility Study

    Scott J. Swanson;James E. Herndon;Thomas A. D'Amico;Todd L. Demmy

  • Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion

    Carolyn M Dresler;Jemi Olak;James E Herndon;William G Richards

  • The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

    Michael T. Jaklitsch;Francine L. Jacobson;John H.M. Austin;John K. Field

  • Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer

    Patrick C. Ma;Ramasamy Jagadeeswaran;Simha Jagadeesh;Maria S. Tretiakova

  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia

    Mohamed Bentires-Alj;J. Guillermo Paez;Frank S. David;Heike Keilhack

  • Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

    Lee M. Krug;Harvey I. Pass;Valerie W. Rusch;Hedy L. Kindler

  • Classification of Human Lung Carcinomas by mRNA Expression Profiling

    Arindam Bhattacharjee;Matthew Meyerson

Frequent Co-Authors

Raphael Bueno
Raphael Bueno Brigham and Women's Hospital
William G. Richards
William G. Richards Brigham and Women's Hospital
Beow Y. Yeap
Beow Y. Yeap Harvard University
James E. Herndon
James E. Herndon Duke University
David H. Harpole
David H. Harpole Duke University
Pasi A. Jänne
Pasi A. Jänne Harvard University
Lucian R. Chirieac
Lucian R. Chirieac Brigham and Women's Hospital
Bruce E. Johnson
Bruce E. Johnson Harvard University
Karl T. Kelsey
Karl T. Kelsey Brown University
Brock C. Christensen
Brock C. Christensen Dartmouth College

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medical careers beyond traditional pathways, there are several flexible online options to consider. Many students choose rn to bsn online programs to upgrade their qualifications while working, offering both affordability and convenience for registered nurses seeking advancement.

For those with a bachelor’s degree outside of nursing, direct entry msn programs for non-nursing majors provide a fast-track into advanced practice nursing, helping you pivot your career towards healthcare leadership or specialized clinical roles.

If you’re looking to start a nursing career quickly, adn nursing programs offer accessible entry points, requiring less time to complete compared to traditional four-year degrees.

Not all healthcare roles require direct patient care. Those interested in the administrative side can explore medical billing and coding schools online with financial aid, opening doors to vital support positions in hospitals, clinics, and insurance companies.

Each of these online pathways offers unique flexibility, making it easier to balance your studies with other commitments while positioning yourself for a rewarding career in healthcare.

Best Scientists Citing David J. Sugarbaker